Accenture (ACN)
(Delayed Data from NYSE)
$360.71 USD
+4.58 (1.29%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $360.72 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$360.71 USD
+4.58 (1.29%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $360.72 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Zacks News
5 Crypto-Related Stocks With Upside as Bitcoin Hits All-Time High
by Ritujay Ghosh
Crypto-related stocks like NVDA, IBKR, BLK, ACN and CME are set to gain from Bitcoin's ongoing rally.
Are Options Traders Betting on a Big Move in Accenture (ACN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Accenture (ACN) stock based on the movements in the options market lately.
Accenture (ACN) Stock Moves -0.5%: What You Should Know
by Zacks Equity Research
Accenture (ACN) concluded the recent trading session at $344.82, signifying a -0.5% move from its prior day's close.
Brokers Suggest Investing in Accenture (ACN): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Accenture (ACN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Accenture (ACN) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $363.04, marking a +0.48% move from the previous day.
Bitcoin Surpasses $71,000: Buy 4 Crypto Stocks With Growth Potential
by Ritujay Ghosh
Stocks like IBKR, CME, ACN and BLK are poised to benefit from the ongoing Bitcoin rally.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
UIS Stock Ahead of Q3 Earnings Report: To Buy or Not to Buy?
by Zacks Equity Research
Unisys' third-quarter 2024 results are expected to benefit from strong demand for Digital Workplace Solutions and Cloud-Based Solutions.
Is Unisys Stock a Buy, Sell or Hold at 0.19X Price/Sales Ratio?
by Aniruddha Ganguly
UIS is an attractive stock for growth-oriented investors, given its portfolio strength and strong partner base.
Can VRT's Q3 Earnings Beat & Raised 2024 View Push the Stock Higher?
by Zacks Equity Research
Vertiv's third-quarter 2024 results reflect strong order increase, solid organic growth and margin expansion.
Vertiv Holdings Co. (VRT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Vertiv (VRT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Accenture (ACN) Stock Moves -0.31%: What You Should Know
by Zacks Equity Research
The latest trading day saw Accenture (ACN) settling at $370.63, representing a -0.31% change from its previous close.
Interpublic Group Earnings Meet Estimates in Q3, Revenues Miss
by Zacks Equity Research
IPG's third-quarter 2024 total revenues decline year over year. Earnings remain flat with the year-ago quarter.
3 Reasons Why Growth Investors Shouldn't Overlook Accenture (ACN)
by Zacks Equity Research
Accenture (ACN) possesses solid growth attributes, which could help it handily outperform the market.
Bitcoin on Track to Hit $70,000: 4 Crypto-Centric Stocks With Upside
by Ritujay Ghosh
Bitcoin-centric stocks like NVDA, CME, IBKR and ACN are poised to gain from the ongoing cryptocurrency rally.
The Zacks Analyst Blog Highlights AstraZeneca, Accenture, AT&T and National Presto Industries
by Zacks Equity Research
AstraZeneca, Accenture, AT&T and National Presto Industries are part of the Zacks top Analyst Blog.
Top Research Reports for AstraZeneca, Accenture & AT&T
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Accenture plc (ACN) and AT&T Inc. (T), as well as a micro-cap stock National Presto Industries, Inc. (NPK).
Omnicom Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
by Zacks Equity Research
Organic growth across the Experiential, Advertising & Media, Public Relations, and Brand & Retail Commerce segments fuels OMC's third-quarter 2024 revenues.
Investors Heavily Search Accenture PLC (ACN): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Wall Street Bulls Look Optimistic About Accenture (ACN): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Accenture (ACN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Here's Why Accenture (ACN) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Ideas feature highlights: Nvidia, Taiwan Semiconductor and Accenture
by Zacks Equity Research
Nvidia, Taiwan Semiconductor and Accenture have been highlighted in this Investment Ideas article.
AI News: Blackwell Demand, OpenAI Raise
by Andrew Rocco
Many Wall Street Analysts are concerned that the AI spending sugar high will wear off. Stock Strategist Andrew Rocco explains how Nvidia's "insane demand" and OpenAI's massive valuation suggest that the bull market in AI spend is unlikely to subside soon.
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Accenture (ACN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.